Most recently, an alternative cell-internalizing RNA aptamer that binds to the human epidermal growth factor receptor 2 (HER2) was developed for delivering therapeutic siRNA to HER2-expressing breast cancer cells (Thiel et al., 2012). The gene discussed is ERBB2; the disease is breast cancer.